Market

Thermo Fisher to Open Advanced Bioprocess Center in Hyderabad
Management & Regulatory Thermo Fisher to Open Advanced Bioprocess Center in Hyderabad

Thermo Fisher Scientific is making significant strides in the Indian biopharma market with the announcement of a new bioprocess design center (BDC) in Genome Valley, Hyderabad. This 10,000 square-foot facility, expected to open early next year, is part of a broader initiative by the company to

Fujifilm Diosynth To Expand Hillerød Facility, Adding 2,200 Jobs
Management & Regulatory Fujifilm Diosynth To Expand Hillerød Facility, Adding 2,200 Jobs

Fujifilm Diosynth Biotechnologies, a leading CDMO in the field of biologics, vaccines, advanced therapies, and oncolytic viruses, has embarked on the initial phase of a massive expansion project at their facility in Hillerød, Denmark. By adding six mammalian cell bioreactors to the existing

October 2024 Sees Record Biotech Investments Focused on Oncology
Management & Regulatory October 2024 Sees Record Biotech Investments Focused on Oncology

October 2024 saw a surge in biotech investments, with notable contributions from companies across North America, Europe, and the Asia-Pacific regions. Major players like Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics secured substantial funding, reflecting the growing

Is Arbutus Biopharma Positioned for Significant Growth Potential?
Management & Regulatory Is Arbutus Biopharma Positioned for Significant Growth Potential?

Recent developments and analyst perspectives have spotlighted Arbutus Biopharma (NASDAQ: ABUS), indicating a promising growth trajectory for this biopharmaceutical company. Chardan Capital's recent decision to raise its target price for Arbutus Biopharma from $4.00 to $4.50 signifies a potential

Rallybio's Battle: Navigating Financial Turbulence in Biotech Innovation
Management & Regulatory Rallybio's Battle: Navigating Financial Turbulence in Biotech Innovation

Rallybio, a small biotech firm, is on a mission to develop treatments for rare diseases, with a particular focus on fetal and neonatal alloimmune thrombocytopenia (FNAIT). This rare but potentially fatal disease results from platelet incompatibility between pregnant mothers and their unborn

Viking's Obesity Drug Shows Promising Results Amid Competitive Market
Management & Regulatory Viking's Obesity Drug Shows Promising Results Amid Competitive Market

The recent results of a clinical trial for an oral obesity drug developed by Viking Therapeutics have generated significant interest. The drug has shown promise in early-phase trials, capturing the attention of Wall Street analysts and investors alike. The study results, revealed at a medical

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later